Teal Health Raises $10 Million Led by Emerson Collective for At-Home Cervical Cancer Screening Test

Teal Health has successfully raised $10 million in funding to develop the first-ever at-home cervical cancer screening test. This innovative screening method, which is covered by insurance, aims to provide a more convenient and comfortable alternative to traditional Pap smears. The funding round was led by Emerson Collective and Forerunner Ventures, with Nicole Johnson from Forerunner VC noted as a key leader in the initiative. The company, which previously secured investment from Chingona Ventures during its pre-seed round in 2021, is expected to enhance patient adherence and health outcomes through this new testing approach.